Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,6.460646522011742e-70,106.070796460177,16898.69302842701,"['RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS6KA6', 'RPS17', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'RPS20', 'FAU', 'RPS21', 'RPS24', 'RPS23']",2.2676869292261212e-67,0,0,78
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,1.6698535473676032e-45,44.27842003853564,4565.264209774933,"['COX7B', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'COX8A', 'NDUFC1', 'COX6B1', 'NDUFS6', 'NDUFS5', 'NDUFS3', 'SLC25A5', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'ATP5MC1', 'UCP3', 'COX11', 'NDUFV1', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'UQCRQ', 'NDUFAB1', 'ATP5PO']",2.930592975630144e-43,0,0,57
3,Oxidative phosphorylation WP623,3.7159174901463843e-25,36.42521166509878,2048.991068802656,"['NDUFB9', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'NDUFV1', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'ATP5PO']",4.3476234634712694e-23,0,0,32
4,Nonalcoholic fatty liver disease WP4396,1.2022314234130028e-21,7.915182315252759,381.2751838257497,"['NDUFA13', 'COX7B', 'NDUFA11', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'MLX', 'UQCRFS1', 'COX8A', 'NDUFC1', 'COX6B1', 'NDUFS6', 'DDIT3', 'NDUFS5', 'NDUFS3', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'CYC1', 'NDUFV1', 'NDUFA8', 'XBP1', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'UQCRQ', 'NDUFAB1', 'CYCS', 'BAX']",1.05495807404491e-19,0,0,49
5,Mitochondrial complex I assembly model OXPHOS system WP4324,5.646836243218704e-21,28.221597417473706,1315.780941437645,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFB7', 'DMAC1', 'NDUFB10', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'TMEM186', 'NDUFV1', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4', 'NDUFAB1', 'NDUFS3', 'TMEM126B']",3.9640790427395303e-19,0,0,28
6,Mitochondrial CIV Assembly WP4922,1.1590806842317278e-18,49.63839701770736,2050.0114177972605,"['COX8A', 'COA3', 'COX7B', 'SURF1', 'COX16', 'PET100', 'NDUFA4', 'TACO1', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'PET117', 'COX6B1', 'SCO2', 'COX11', 'COX14', 'COX20']",6.780622002755608e-17,0,0,22
7,Cellular Proteostasis WP4918,1.0830612757975032e-06,inf,inf,"['VBP1', 'PFDN1', 'PFDN2', 'PFDN4', 'PFDN5', 'PFDN6']",5.4307786829274804e-05,0,0,6
8,Mitochondrial complex III assembly WP4921,1.3758774425270073e-06,23.759582950015332,320.6692841534451,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",6.0366622790872446e-05,0,0,8
9,Pyrimidine metabolism WP4022,0.00010788724109700164,3.7237654320987654,34.01445211054455,"['POLR3GL', 'NME2', 'NME3', 'NME1', 'NT5C', 'POLE4', 'POLD4', 'ZNRD1', 'POLE3', 'TK1', 'POLR2I', 'DCTPP1', 'POLR2J', 'POLR2K', 'POLR2L']",0.004207602402783063,0,0,15
10,mRNA Processing WP411,0.00017412544633335625,3.527046783625731,30.529180748847534,"['DHX8', 'CELF1', 'NCBP2', 'CELF2', 'LSM2', 'LSM7', 'SNRPD1', 'SNRPG', 'SRSF3', 'SNRPE', 'SNRPB2', 'SNRPF', 'DNAJC8', 'HNRNPA1', 'SRSF9']",0.006111803166300805,0,0,15
11,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.0013410158032823012,17.756186984417965,117.44524279201995,"['COX8A', 'CYP2C8', 'GSTP1', 'COX5A']",0.042790595177462525,0,0,4
12,Nucleotide Excision Repair WP4753,0.008028957730669547,3.660088667820069,17.65883183201568,"['POLE4', 'POLD4', 'RFC2', 'POLE3', 'RAD23A', 'MNAT1', 'GTF2H5']",0.23484701362208427,0,0,7
13,Ciliary landscape WP4352,0.024656355037987715,1.7144901610017889,6.348278039094649,"['RALB', 'DYNLT1', 'NDUFA5', 'SSNA1', 'EXOC6B', 'COPS7A', 'MYL6B', 'DYNLL1', 'COX6C', 'LSM4', 'EHBP1', 'MYL6', 'COPS6', 'IFT22', 'PSMD7', 'TMED1', 'EXOC6', 'SNRPB2', 'DCAF11', 'GLA']",0.5504084245366042,0,0,20
14,DNA Mismatch Repair WP531,0.026902036518190318,4.436296975252063,16.039668116499733,"['POLE4', 'POLD4', 'RFC2', 'POLE3']",0.5504084245366042,0,0,4
15,Proteasome Degradation WP183,0.027646603277811814,2.703604539641944,9.701215493311416,"['PSMB6', 'PSMC5', 'PSMD7', 'H2AFZ', 'PSMC1', 'PSMB10', 'PSMA7']",0.5504084245366042,0,0,7
16,Heme Biosynthesis WP561,0.0288216395047993,17.725526075022874,62.865861313315904,"['UROD', 'HMBS']",0.5504084245366042,0,0,2
17,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.0288216395047993,17.725526075022874,62.865861313315904,"['ELOB', 'ELOC']",0.5504084245366042,0,0,2
18,DNA Repair Pathways Full Network WP4946,0.029764163185305663,2.0815537410693254,7.315516934180831,"['POLE4', 'POLD4', 'DCLRE1C', 'CENPX', 'NTHL1', 'RFC2', 'APEX1', 'POLE3', 'RAD23A', 'MNAT1', 'GTF2H5']",0.5504084245366042,0,0,11
19,Base Excision Repair WP4752,0.029794188222779145,3.4139026111503177,11.994548580905018,"['POLE4', 'POLD4', 'NTHL1', 'APEX1', 'POLE3']",0.5504084245366042,0,0,5
20,Sleep regulation WP3591,0.03549436940312685,2.8038277511961724,9.360245862285236,"['CACNA1I', 'AHCY', 'STAR', 'CRH', 'BTBD9', 'HCRTR1']",0.6229261830248762,0,0,6
21,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.03958444091678522,5.32032967032967,17.18104245716632,"['EIF2S2', 'EIF3D', 'EIF1']",0.6616256553234102,0,0,3
22,Eukaryotic Transcription Initiation WP405,0.045531928205713945,2.958103975535168,9.138593314684373,"['GTF2A2', 'POLR2I', 'MNAT1', 'POLR2J', 'POLR2K']",0.7264412181911635,0,0,5
23,Peroxiredoxin 2 induced ovarian failure WP4873,0.053782410039641515,8.86184812442818,25.90148782599752,"['STAR', 'BAX']",0.7865677468297572,0,0,2
24,Pilocytic astrocytoma WP2253,0.053782410039641515,8.86184812442818,25.90148782599752,"['NF1', 'BRAF']",0.7865677468297572,0,0,2
25,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.07279393865436151,3.7994505494505493,9.955026204659495,"['RRAS2', 'BRAF', 'HRAS']",0.9998486240585546,0,0,3
26,Mitochondrial CII Assembly WP4920,0.10154848080556246,inf,inf,['SDHAF1'],0.9998486240585546,0,0,1
27,Selenium Micronutrient Network WP15,0.11003129022164067,1.6999529798989068,3.7517800721187764,"['SELENOM', 'PRDX5', 'GPX4', 'SELENOS', 'DIO2', 'SELENOW', 'TXN', 'SELENOK', 'SELENOH']",0.9998486240585546,0,0,9
28,Overview of nanoparticle effects WP3287,0.11475366898123758,2.9545177045177047,6.396434680997327,"['COL4A1', 'BAX', 'PTK2']",0.9998486240585546,0,0,3
29,TCA cycle in senescence WP5050,0.11728065044929069,4.430009149130832,9.494331349966304,"['ME1', 'BRAF']",0.9998486240585546,0,0,2
30,Dual hijack model of Vif in HIV infection WP3300,0.11728065044929069,4.430009149130832,9.494331349966304,"['ELOB', 'ELOC']",0.9998486240585546,0,0,2
31,Intraflagellar transport proteins binding to dynein WP4532,0.13843716860904534,2.6587912087912087,5.2573307857045535,"['IFT22', 'DYNLT1', 'DYNLL1']",0.9998486240585546,0,0,3
32,Nanomaterial induced apoptosis WP2507,0.13843716860904534,2.6587912087912087,5.2573307857045535,"['ENDOG', 'BAX', 'CYCS']",0.9998486240585546,0,0,3
33,Ferroptosis WP4313,0.1486709928461496,1.9276027124052653,3.674048389308266,"['MAP1LC3A', 'GPX4', 'FTH1', 'SAT2', 'FTL']",0.9998486240585546,0,0,5
34,Nanoparticle triggered regulated necrosis WP2513,0.1535026995800741,3.5436413540713634,6.640915456167034,"['TRADD', 'FTL']",0.9998486240585546,0,0,2
35,7q11.23 copy number variation syndrome WP4932,0.17358032810489318,1.5065672886479724,2.6381722771682834,"['RFC2', 'ATP5MC2', 'ATP5PO', 'ATP5MC3', 'VPS37B', 'ATP5F1D', 'ACACA', 'ATP5F1E', 'ATP5MC1']",0.9998486240585546,0,0,9
36,BDNF-TrkB Signaling WP3676,0.1786013076748351,1.9696506772583766,3.3929188557488743,"['NTRK2', 'TRPC6', 'BRAF', 'HRAS']",0.9998486240585546,0,0,4
37,TP53 network WP1742,0.18995691684373084,2.2152014652014653,3.679356564199026,"['SUMO1', 'GADD45A', 'BAX']",0.9998486240585546,0,0,3
38,Copper homeostasis WP3286,0.20001827949492168,1.8657918857639055,3.00270567678631,"['SCO2', 'COX17', 'COX11', 'ATOX1']",0.9998486240585546,0,0,4
39,Regulation of Actin Cytoskeleton WP51,0.21024151006574338,1.3477330902205547,2.1017875454411015,"['FGF17', 'CHRM3', 'TMSB4X', 'CHRM5', 'BRK1', 'RAC3', 'RRAS2', 'BRAF', 'ARHGAP35', 'PTK2', 'SSH1', 'PAK4']",0.9998486240585546,0,0,12
40,CAMKK2  Pathway WP4874,0.22215051256631194,1.7723189734188818,2.666276915820519,"['CHRM3', 'FIS1', 'MAP1LC3A', 'STIM1']",0.9998486240585546,0,0,4
41,RalA downstream regulated genes WP2290,0.23047074546225296,2.5306495882891125,3.7140606522388264,"['RAC3', 'HRAS']",0.9998486240585546,0,0,2
42,Nephrotic syndrome WP4758,0.24487959736576184,1.6877482432019555,2.374642586051721,"['TRPC6', 'TTC21B', 'PTPRO', 'PAX2']",0.9998486240585546,0,0,4
43,Gastric Cancer Network 2 WP2363,0.24537225950098396,1.8983516483516483,2.667143811507588,"['AHCTF1', 'S100A6', 'COL9A3']",0.9998486240585546,0,0,3
44,Splicing factor NOVA regulated synaptic proteins WP4148,0.26808876054899305,1.6108657611865678,2.120603543329565,"['KCNQ2', 'GRIK2', 'ANK3', 'STX2']",0.9998486240585546,0,0,4
45,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.26808876054899305,1.6108657611865678,2.120603543329565,"['PPP1R14B', 'XBP1', 'MAP1LC3A', 'DDIT3']",0.9998486240585546,0,0,4
46,Serotonin and anxiety WP3947,0.2698899488625042,2.2140896614821592,2.8998840070524166,"['POMC', 'CRH']",0.9998486240585546,0,0,2
47,Methionine De Novo and Salvage Pathway WP3580,0.2698899488625042,2.2140896614821592,2.8998840070524166,"['AHCY', 'TXN']",0.9998486240585546,0,0,2
48,Type 2 papillary renal cell carcinoma WP4241,0.27396430088083723,1.7716117216117215,2.2938075102101374,"['SETD2', 'ELOB', 'ELOC']",0.9998486240585546,0,0,3
49,Glycosylation and related congenital defects WP4521,0.27396430088083723,1.7716117216117215,2.2938075102101374,"['DPM2', 'DPM3', 'MPDU1']",0.9998486240585546,0,0,3
50,Parkinson's disease pathway WP2371,0.27396430088083723,1.7716117216117215,2.2938075102101374,"['ATXN2', 'CYCS', 'PARK7']",0.9998486240585546,0,0,3
51,Photodynamic therapy-induced unfolded protein response WP3613,0.27396430088083723,1.7716117216117215,2.2938075102101374,"['NARS', 'XBP1', 'DDIT3']",0.9998486240585546,0,0,3
52,The alternative pathway of fetal androgen synthesis WP4524,0.27477933634850044,4.426873857404022,5.7185777308740064,['STAR'],0.9998486240585546,0,0,1
53,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.27477933634850044,4.426873857404022,5.7185777308740064,['MAP1LC3A'],0.9998486240585546,0,0,1
54,Mevalonate pathway WP3963,0.27477933634850044,4.426873857404022,5.7185777308740064,['PMVK'],0.9998486240585546,0,0,1
55,Mitochondrial fatty acid synthesis pathway WP4317,0.27477933634850044,4.426873857404022,5.7185777308740064,['ACACA'],0.9998486240585546,0,0,1
56,IL-18 signaling pathway WP4754,0.28976420746044973,1.1826679046734756,1.464956262928148,"['NRN1', 'TOMM40', 'IMP3', 'CD81', 'COX17', 'NDUFC1', 'BPGM', 'RND2', 'GRM7', 'RASA3', 'NACA', 'TMSB4X', 'CYCS', 'BAX', 'PTPN7', 'RPS11', 'NOX1', 'ITM2C']",0.9998486240585546,0,0,18
57,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.30286742982765397,1.6607142857142858,1.9836569427118584,"['MAP1LC3A', 'ACACA', 'FTL']",0.9998486240585546,0,0,3
58,ERK Pathway in Huntington's Disease WP3853,0.309245323697114,1.9678763850767511,2.309539849061465,"['NTRK2', 'HRAS']",0.9998486240585546,0,0,2
59,Fatty acid transporters WP5061,0.309245323697114,1.9678763850767511,2.309539849061465,"['FABP6', 'FABP7']",0.9998486240585546,0,0,2
60,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.309245323697114,1.9678763850767511,2.309539849061465,"['RPS6', 'ACACA']",0.9998486240585546,0,0,2
61,MET in type 1 papillary renal cell carcinoma WP4205,0.3209600161044973,1.3841743119266054,1.5730292888844926,"['RPL11', 'BRAF', 'HRAS', 'PTK2', 'PAK4']",0.9998486240585546,0,0,5
62,SARS-CoV-2 mitochondrial interactions WP5038,0.3318937614431664,1.562863606981254,1.723745344514148,"['NDUFB9', 'PHB', 'NOX1']",0.9998486240585546,0,0,3
63,VEGFA-VEGFR2 Signaling Pathway WP3888,0.33930749757765877,1.0999172932330827,1.188843967781352,"['RPL5', 'SET', 'TXN', 'RPL10A', 'HDAC9', 'ACACA', 'RPL7', 'RPL18A', 'TMSB4X', 'FAM120A', 'GRB10', 'RPLP2', 'ELOC', 'RPS11', 'TMSB10', 'ACP1', 'HRAS', 'SDF2L1', 'SSR4', 'RPS6', 'SARS', 'RPL13A', 'FRS2', 'PTK2', 'CYP2C8', 'CYCS', 'RPL27', 'RPL26', 'ALDOA', 'EIF3D', 'PTMA']",0.9998486240585546,0,0,31
64,"Degradation pathway of sphingolipids, including diseases WP4153",0.3484449691222736,2.9509445460085315,3.11110696999215,['GLA'],0.9998486240585546,0,0,1
65,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.36052378236792043,1.2653810835629018,1.2909384331584872,"['RALB', 'GADD45A', 'RAC3', 'CYCS', 'BAX', 'BRAF']",0.9998486240585546,0,0,6
66,Translation Factors WP107,0.38751752559844604,1.311878331126727,1.2436530540784971,"['EEF1B2', 'EIF2S2', 'EIF3D', 'EIF1']",0.9998486240585546,0,0,4
67,Vitamin D-sensitive calcium signaling in depression WP4698,0.3896527891888048,1.3980624638519374,1.3176727824299115,"['GPX4', 'KCNQ2', 'PVALB']",0.9998486240585546,0,0,3
68,MAPK Cascade WP422,0.3896527891888048,1.3980624638519374,1.3176727824299115,"['RASA3', 'BRAF', 'HRAS']",0.9998486240585546,0,0,3
69,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.4046650992383075,1.2298674821610602,1.1126555390977895,"['LAMA5', 'TRPC6', 'PTPRO', 'PAX2', 'PTK2']",0.9998486240585546,0,0,5
70,Cytosolic DNA-sensing pathway WP4655,0.41139161201019914,1.2648945921173236,1.1234916346378498,"['POLR3GL', 'TRADD', 'POLR2K', 'POLR2L']",0.9998486240585546,0,0,4
71,Biotin Metabolism (including IEMs) WP5031,0.4146340070307317,2.2129798903107862,1.9482168930074404,['ACACA'],0.9998486240585546,0,0,1
72,Trans-sulfuration pathway WP2333,0.4146340070307317,2.2129798903107862,1.9482168930074404,['AHCY'],0.9998486240585546,0,0,1
73,Valproic acid pathway WP3871,0.4146340070307317,2.2129798903107862,1.9482168930074404,['HSD17B10'],0.9998486240585546,0,0,1
74,FTO Obesity Variant Mechanism WP3407,0.4146340070307317,2.2129798903107862,1.9482168930074404,['FTO'],0.9998486240585546,0,0,1
75,MED and Pseudoachondroplasia genes WP4789,0.4146340070307317,2.2129798903107862,1.9482168930074404,['COL9A3'],0.9998486240585546,0,0,1
76,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.4146340070307317,2.2129798903107862,1.9482168930074404,['PMVK'],0.9998486240585546,0,0,1
77,Corticotropin-releasing hormone signaling pathway WP2355,0.4170050208149766,1.1806550352004896,1.0326682111143648,"['POMC', 'STAR', 'CRH', 'BRAF', 'ACACA', 'PTK2']",0.9998486240585546,0,0,6
78,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.42338595472768925,1.4754498322659348,1.268106480618313,"['CD63', 'CD81']",0.9998486240585546,0,0,2
79,Genotoxicity pathway WP4286,0.4350620887469832,1.2211511109706374,1.0163231920268816,"['RPS27', 'GADD45A', 'RAPGEF2', 'TRIAP1']",0.9998486240585546,0,0,4
80,p38 MAPK Signaling Pathway WP400,0.44609043794145725,1.2646520146520146,1.0208695629535427,"['TRADD', 'DDIT3', 'HRAS']",0.9998486240585546,0,0,3
81,Alpha 6 Beta 4 signaling pathway WP244,0.47352826807794757,1.207042957042957,0.9023173193818605,"['LAMA5', 'HRAS', 'PTK2']",0.9998486240585546,0,0,3
82,Bladder cancer WP2828,0.47352826807794757,1.207042957042957,0.9023173193818605,"['DAPK1', 'BRAF', 'HRAS']",0.9998486240585546,0,0,3
83,Serotonin and anxiety-related events WP3944,0.4741046520196418,1.770201096892139,1.321149222424441,['CRH'],0.9998486240585546,0,0,1
84,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.4741046520196418,1.770201096892139,1.321149222424441,['SST'],0.9998486240585546,0,0,1
85,Cytosine methylation WP3585,0.4741046520196418,1.770201096892139,1.321149222424441,['TET3'],0.9998486240585546,0,0,1
86,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.4741046520196418,1.770201096892139,1.321149222424441,['AHCY'],0.9998486240585546,0,0,1
87,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.4741046520196418,1.770201096892139,1.321149222424441,['VEGFB'],0.9998486240585546,0,0,1
88,Non-homologous end joining WP438,0.4741046520196418,1.770201096892139,1.321149222424441,['DCLRE1C'],0.9998486240585546,0,0,1
89,Purine metabolism WP4792,0.4741046520196418,1.770201096892139,1.321149222424441,['APRT'],0.9998486240585546,0,0,1
90,Melanoma WP4685,0.48698931946209606,1.1064220183486237,0.7960851224218555,"['GADD45A', 'NF1', 'BAX', 'BRAF', 'HRAS']",0.9998486240585546,0,0,5
91,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.49386977954075795,1.2644098810612991,0.8920201827854947,"['H2AFJ', 'H2AFZ']",0.9998486240585546,0,0,2
92,Modulators of TCR signaling and T cell activation WP5072,0.5041682976486045,1.1063244729605866,0.7576609416069646,"['FIBP', 'NDUFB10', 'ELOB', 'RNF7']",0.9998486240585546,0,0,4
93,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.5263753506081226,1.0726883870788546,0.6883878247460337,"['PSMC5', 'PSMD7', 'PSMC1', 'STUB1']",0.9998486240585546,0,0,4
94,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.5270027639587694,1.1799939005794449,0.7558444862054574,"['GRB10', 'HRAS']",0.9998486240585546,0,0,2
95,Androgen receptor signaling pathway WP138,0.5270852868132364,1.0411062496623993,0.6667170597726836,"['SUMO1', 'BAG1', 'DSTN', 'STUB1', 'PARK7', 'PTK2']",0.9998486240585546,0,0,6
96,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.5275382806767619,1.4750152346130407,0.943322166286609,['STAR'],0.9998486240585546,0,0,1
97,Codeine and Morphine Metabolism WP1604,0.5275382806767619,1.4750152346130407,0.943322166286609,['CYP2C8'],0.9998486240585546,0,0,1
98,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.5275382806767619,1.4750152346130407,0.943322166286609,['CYP2C8'],0.9998486240585546,0,0,1
99,Homologous recombination WP186,0.5275382806767619,1.4750152346130407,0.943322166286609,['POLD4'],0.9998486240585546,0,0,1
100,Insulin signaling in adipocytes (diabetic condition) WP3635,0.5275382806767619,1.4750152346130407,0.943322166286609,['RPS6'],0.9998486240585546,0,0,1
101,Insulin signaling in adipocytes (normal condition) WP3634,0.5275382806767619,1.4750152346130407,0.943322166286609,['RPS6'],0.9998486240585546,0,0,1
102,Iron metabolism in placenta WP2007,0.5275382806767619,1.4750152346130407,0.943322166286609,['FTH1'],0.9998486240585546,0,0,1
103,Leptin and adiponectin WP3934,0.5275382806767619,1.4750152346130407,0.943322166286609,['ACACA'],0.9998486240585546,0,0,1
104,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.5275382806767619,1.4750152346130407,0.943322166286609,['PTK2'],0.9998486240585546,0,0,1
105,Nanomaterial-induced inflammasome activation WP3890,0.5275382806767619,1.4750152346130407,0.943322166286609,['NOX1'],0.9998486240585546,0,0,1
106,Circadian rhythm related genes WP3594,0.5307472636053239,1.0112650046168052,0.6406053690985883,"['KDM5A', 'AHCY', 'STAR', 'KCNH7', 'CAVIN3', 'CRH', 'AVP', 'BTRC', 'RPS27A', 'BTBD9', 'UBA52', 'HCRTR1']",0.9998486240585546,0,0,12
107,TNF-alpha signaling pathway WP231,0.5446589881776304,1.020979020979021,0.6203421463547065,"['TRADD', 'BAX', 'TXN', 'BTRC', 'HRAS', 'NOX1']",0.9998486240585546,0,0,6
108,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.5517165389441389,1.0618681318681318,0.6315151508960589,"['NTRK2', 'NF1', 'HRAS']",0.9998486240585546,0,0,3
109,DNA Replication WP466,0.5517165389441389,1.0618681318681318,0.6315151508960589,"['POLD4', 'RFC2', 'UBA52']",0.9998486240585546,0,0,3
110,Unfolded protein response WP4925,0.5586325521031267,1.1061299176578225,0.6440589144073744,"['XBP1', 'DDIT3']",0.9998486240585546,0,0,2
111,Nanoparticle-mediated activation of receptor signaling WP2643,0.5586325521031267,1.1061299176578225,0.6440589144073744,"['HRAS', 'PTK2']",0.9998486240585546,0,0,2
112,"Relationship between inflammation, COX-2 and EGFR WP4483",0.5586325521031267,1.1061299176578225,0.6440589144073744,"['BRAF', 'HRAS']",0.9998486240585546,0,0,2
113,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.5619378384851356,1.0016113103591662,0.5772927442365703,"['POMC', 'RPS6KA6', 'RPS6', 'DIO2', 'FRS2', 'HRAS']",0.9998486240585546,0,0,6
114,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.5619378384851356,1.0016113103591662,0.5772927442365703,"['RPS6', 'NF1', 'RRAS2', 'BAX', 'BRAF', 'HRAS']",0.9998486240585546,0,0,6
115,Non-small cell lung cancer WP4255,0.5648974652161516,1.005421184320267,0.5742071400231941,"['GADD45A', 'CYCS', 'BAX', 'BRAF', 'HRAS']",0.9998486240585546,0,0,5
116,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.5755472216396429,1.2641681901279707,0.6983694911414919,['DLL3'],0.9998486240585546,0,0,1
117,Biomarkers for pyrimidine metabolism disorders WP4584,0.5755472216396429,1.2641681901279707,0.6983694911414919,['NT5C'],0.9998486240585546,0,0,1
118,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.5755472216396429,1.2641681901279707,0.6983694911414919,['BAX'],0.9998486240585546,0,0,1
119,Leptin signaling pathway WP2034,0.5834200332777904,0.9829765545361876,0.5296748357459342,"['RPS6', 'BAX', 'HRAS', 'ACACA', 'PTK2']",0.9998486240585546,0,0,5
120,Sphingolipid pathway WP1422,0.5887225455778228,1.0409558150799203,0.5514986681959249,"['CERS6', 'GBA2']",0.9998486240585546,0,0,2
121,Disruption of postsynaptic signaling by CNV WP4875,0.5887225455778228,1.0409558150799203,0.5514986681959249,"['DLG2', 'DLGAP1']",0.9998486240585546,0,0,2
122,Ethanol effects on histone modifications WP3996,0.5887225455778228,1.0409558150799203,0.5514986681959249,"['AHCY', 'HDAC9']",0.9998486240585546,0,0,2
123,Imatinib and Chronic Myeloid Leukemia WP3640,0.5887225455778228,1.0409558150799203,0.5514986681959249,"['GADD45A', 'SKP2']",0.9998486240585546,0,0,2
124,Neural Crest Cell Migration in Cancer WP4565,0.5998370817211153,0.983007733007733,0.5024124911716691,"['NTRK2', 'TRIO', 'PAK4']",0.9998486240585546,0,0,3
125,Cell migration and invasion through p75NTR WP4561,0.6172590550854067,0.9830232794551185,0.4742757822021002,"['NTRK2', 'TRIO']",0.9998486240585546,0,0,2
126,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.6172590550854067,0.9830232794551185,0.4742757822021002,"['SUPT4H1', 'HDAC9']",0.9998486240585546,0,0,2
127,Tamoxifen metabolism WP691,0.6186817469952562,1.106032906764168,0.5310774933041729,['CYP2C8'],0.9998486240585546,0,0,1
128,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.6186817469952562,1.106032906764168,0.5310774933041729,['IDH3B'],0.9998486240585546,0,0,1
129,Cholesterol Biosynthesis Pathway WP197,0.6186817469952562,1.106032906764168,0.5310774933041729,['PMVK'],0.9998486240585546,0,0,1
130,Cysteine and methionine catabolism WP4504,0.6186817469952562,1.106032906764168,0.5310774933041729,['AHCY'],0.9998486240585546,0,0,1
131,Genes targeted by miRNAs in adipocytes WP1992,0.6186817469952562,1.106032906764168,0.5310774933041729,['TMSB4X'],0.9998486240585546,0,0,1
132,Nanoparticle triggered autophagic cell death WP2509,0.6186817469952562,1.106032906764168,0.5310774933041729,['MAP1LC3A'],0.9998486240585546,0,0,1
133,Nephrogenesis WP5052,0.6186817469952562,1.106032906764168,0.5310774933041729,['PAX2'],0.9998486240585546,0,0,1
134,Pyrimidine metabolism and related diseases WP4225,0.6186817469952562,1.106032906764168,0.5310774933041729,['NT5C'],0.9998486240585546,0,0,1
135,Aryl Hydrocarbon Receptor Netpath WP2586,0.6225855883096414,0.9478021978021978,0.4491389787024254,"['AIP', 'NF1', 'HRAS']",0.9998486240585546,0,0,3
136,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.6225855883096414,0.9478021978021978,0.4491389787024254,"['NDUFA13', 'COPS6', 'ACAP1']",0.9998486240585546,0,0,3
137,Pancreatic adenocarcinoma pathway WP4263,0.6276925219422299,0.9309361558165385,0.4335414801565785,"['RALB', 'GADD45A', 'RAC3', 'BAX', 'BRAF', 'PAK4']",0.9998486240585546,0,0,6
138,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.6293182326649195,0.9310627623136668,0.4311921254097977,"['APEX1', 'RPS6', 'BRAF', 'HRAS']",0.9998486240585546,0,0,4
139,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.644247032747825,0.9311889054750325,0.4094186524210657,"['BAX', 'BRAF']",0.9998486240585546,0,0,2
140,MECP2 and Associated Rett Syndrome WP3584,0.6480983630809493,0.9070953488918658,0.3934188629740772,"['SST', 'RPS6', 'TET3', 'NF1']",0.9998486240585546,0,0,4
141,Ras signaling WP4223,0.6521460025525266,0.9173048805959758,0.3921357388810122,"['NTRK2', 'GNG10', 'GNG3', 'RALB', 'RASA3', 'NF1', 'RAC3', 'RRAS2', 'RASAL2', 'HRAS', 'PAK4']",0.9998486240585546,0,0,11
142,Computational Model of Aerobic Glycolysis WP4629,0.6574363557566347,0.9830387974812106,0.4122936645031493,['ALDOA'],0.9998486240585546,0,0,1
143,Cori Cycle WP1946,0.6574363557566347,0.9830387974812106,0.4122936645031493,['ALDOA'],0.9998486240585546,0,0,1
144,"GPCRs, Class B Secretin-like WP334",0.6574363557566347,0.9830387974812106,0.4122936645031493,['ADGRL2'],0.9998486240585546,0,0,1
145,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.6574363557566347,0.9830387974812106,0.4122936645031493,['BAX'],0.9998486240585546,0,0,1
146,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.6574363557566347,0.9830387974812106,0.4122936645031493,['PTK2'],0.9998486240585546,0,0,1
147,Nucleotide metabolism WP404,0.6574363557566347,0.9830387974812106,0.4122936645031493,['NME2'],0.9998486240585546,0,0,1
148,Purine metabolism and related disorders WP4224,0.6574363557566347,0.9830387974812106,0.4122936645031493,['APRT'],0.9998486240585546,0,0,1
149,Integrin-mediated Cell Adhesion WP185,0.6583282086779535,0.8991922304711211,0.37590881776451307,"['RAC3', 'BRAF', 'ITGAE', 'HRAS', 'PTK2', 'PAK4']",0.9998486240585546,0,0,6
150,Exercise-induced Circadian Regulation WP410,0.6653703180507665,0.8844322344322344,0.36032788456769105,"['SUMO1', 'GSTP1', 'UCP3']",0.9998486240585546,0,0,3
151,p53 transcriptional gene network WP4963,0.6653703180507665,0.8844322344322344,0.36032788456769105,"['SIVA1', 'GADD45A', 'BAX']",0.9998486240585546,0,0,3
152,Endometrial cancer WP4155,0.6837236649176192,0.8626679484026738,0.32798759764577246,"['GADD45A', 'BAX', 'BRAF', 'HRAS']",0.9998486240585546,0,0,4
153,Small cell lung cancer WP4658,0.687348594165928,0.8695298740008129,0.32599866263747473,"['LAMA5', 'COL4A1', 'GADD45A', 'CYCS', 'BAX', 'PTK2']",0.9998486240585546,0,0,6
154,Galanin receptor pathway WP4970,0.6922554225602018,0.8846435100548447,0.3253721339910132,['POMC'],0.9998486240585546,0,0,1
155,Glutathione metabolism WP100,0.6922554225602018,0.8846435100548447,0.3253721339910132,['GPX4'],0.9998486240585546,0,0,1
156,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.6922554225602018,0.8846435100548447,0.3253721339910132,['GRM7'],0.9998486240585546,0,0,1
157,ID signaling pathway WP53,0.6922554225602018,0.8846435100548447,0.3253721339910132,['PAX2'],0.9998486240585546,0,0,1
158,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.6922554225602018,0.8846435100548447,0.3253721339910132,['NRG3'],0.9998486240585546,0,0,1
159,MTHFR deficiency WP4288,0.6922554225602018,0.8846435100548447,0.3253721339910132,['CYCS'],0.9998486240585546,0,0,1
160,NOTCH1 regulation of endothelial cell calcification WP3413,0.6922554225602018,0.8846435100548447,0.3253721339910132,['DLL3'],0.9998486240585546,0,0,1
161,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.6922554225602018,0.8846435100548447,0.3253721339910132,['ANAPC11'],0.9998486240585546,0,0,1
162,Signaling of Hepatocyte Growth Factor Receptor WP313,0.6936691207938672,0.8423299786520281,0.30809078428567177,"['HRAS', 'PTK2']",0.9998486240585546,0,0,2
163,ErbB signaling pathway WP673,0.7146734487113054,0.8339103340834343,0.28013512802505114,"['NRG3', 'BRAF', 'HRAS', 'PTK2', 'PAK4']",0.9998486240585546,0,0,5
164,Amyotrophic lateral sclerosis (ALS) WP2447,0.7161762486195389,0.8039590784330034,0.2683848431536114,"['TOMM40', 'BAX']",0.9998486240585546,0,0,2
165,Aryl Hydrocarbon Receptor Pathway WP2873,0.7161762486195389,0.8039590784330034,0.2683848431536114,"['AIP', 'BAX']",0.9998486240585546,0,0,2
166,Histone Modifications WP2369,0.7161762486195389,0.8039590784330034,0.2683848431536114,"['SETD2', 'SET']",0.9998486240585546,0,0,2
167,3q29 copy number variation syndrome WP4906,0.7227207976373416,0.8037795537795538,0.26101318593767514,"['DYNLT1', 'NCBP2', 'DYNLL1']",0.9998486240585546,0,0,3
168,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.7227207976373416,0.8037795537795538,0.26101318593767514,"['BEX3', 'RNF7', 'PTK2']",0.9998486240585546,0,0,3
169,Netrin-UNC5B signaling pathway WP4747,0.7227207976373416,0.8037795537795538,0.26101318593767514,"['ARHGEF12', 'DAPK1', 'PTK2']",0.9998486240585546,0,0,3
170,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.7235382740437932,0.8041382748878179,0.26022061979902006,['BRAF'],0.9998486240585546,0,0,1
171,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.7235382740437932,0.8041382748878179,0.26022061979902006,['EXOC6'],0.9998486240585546,0,0,1
172,Apoptosis Modulation by HSP70 WP384,0.7235382740437932,0.8041382748878179,0.26022061979902006,['CYCS'],0.9998486240585546,0,0,1
173,Transcriptional cascade regulating adipogenesis WP4211,0.7235382740437932,0.8041382748878179,0.26022061979902006,['DDIT3'],0.9998486240585546,0,0,1
174,22q11.2 copy number variation syndrome WP4657,0.7288156201515971,0.8183826027862725,0.25888265192453525,"['RANBP1', 'MRPL40', 'THAP7', 'DGCR6L', 'PAK4']",0.9998486240585546,0,0,5
175,Alzheimer's disease WP2059,0.7322586506035914,0.8035997000249979,0.25041892753943795,"['PSENEN', 'ATP5MD', 'CYCS', 'HSD17B10']",0.9998486240585546,0,0,4
176,Synaptic Vesicle Pathway WP2267,0.7400453754864097,0.7800581771170007,0.23483165948136894,"['SLC32A1', 'PARK7', 'STX2']",0.9998486240585546,0,0,3
177,PPAR signaling pathway WP3942,0.7400453754864097,0.7800581771170007,0.23483165948136894,"['FABP6', 'FABP7', 'ME1']",0.9998486240585546,0,0,3
178,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.7516437517538853,0.7370505789152956,0.2104226347320676,['HRAS'],0.9998486240585546,0,0,1
179,Sphingolipid Metabolism (general overview) WP4725,0.7516437517538853,0.7370505789152956,0.2104226347320676,['CERS6'],0.9998486240585546,0,0,1
180,Sphingolipid Metabolism (integrated pathway) WP4726,0.7516437517538853,0.7370505789152956,0.2104226347320676,['CERS6'],0.9998486240585546,0,0,1
181,Transcription co-factors SKI and SKIL protein partners WP4533,0.7516437517538853,0.7370505789152956,0.2104226347320676,['NF1'],0.9998486240585546,0,0,1
182,Type II diabetes mellitus WP1584,0.7516437517538853,0.7370505789152956,0.2104226347320676,['SURF1'],0.9998486240585546,0,0,1
183,Kallmann's Syndrome WP5074,0.7516437517538853,0.7370505789152956,0.2104226347320676,['FRS2'],0.9998486240585546,0,0,1
184,MAPK pathway in congenital thyroid cancer WP4928,0.7516437517538853,0.7370505789152956,0.2104226347320676,['BRAF'],0.9998486240585546,0,0,1
185,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.7516437517538853,0.7370505789152956,0.2104226347320676,['SCO2'],0.9998486240585546,0,0,1
186,IL-2 signaling pathway WP49,0.7570219656211891,0.7368100030497102,0.20510064972611877,"['RPS6', 'HRAS']",0.9998486240585546,0,0,2
187,Regulation of Microtubule Cytoskeleton WP2038,0.7570219656211891,0.7368100030497102,0.20510064972611877,"['TRIO', 'PARD6A']",0.9998486240585546,0,0,2
188,Acute viral myocarditis WP4298,0.7613712655907399,0.7685011756266688,0.20951968374225913,"['ENDOG', 'RAC3', 'CYCS', 'BAX']",0.9998486240585546,0,0,4
189,Kit receptor signaling pathway WP304,0.772101298350302,0.7365689865689866,0.19050585066934606,"['RPS6', 'GRB10', 'HRAS']",0.9998486240585546,0,0,3
190,Integrated breast cancer pathway WP1984,0.773029987373962,0.7926800527903469,0.20406552166594225,"['GADD45A', 'TRADD', 'NF1', 'BAX', 'BRAF', 'PHB', 'FAU']",0.9998486240585546,0,0,7
191,DNA IR-double strand breaks and cellular response via ATM WP3959,0.7754711157059172,0.7072644098810613,0.17984640730786394,"['DCLRE1C', 'BAX']",0.9998486240585546,0,0,2
192,Interleukin-11 Signaling Pathway WP2332,0.7754711157059172,0.7072644098810613,0.17984640730786394,"['RPS6', 'HRAS']",0.9998486240585546,0,0,2
193,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.7754711157059172,0.7072644098810613,0.17984640730786394,"['STAR', 'HRAS']",0.9998486240585546,0,0,2
194,Oxidative Damage WP3941,0.7754711157059172,0.7072644098810613,0.17984640730786394,"['GADD45A', 'CYCS']",0.9998486240585546,0,0,2
195,Fatty Acid Biosynthesis WP357,0.7768943133980281,0.6802840669385459,0.17173836349826702,['ACACA'],0.9998486240585546,0,0,1
196,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.7768943133980281,0.6802840669385459,0.17173836349826702,['GSTP1'],0.9998486240585546,0,0,1
197,Senescence and Autophagy in Cancer WP615,0.780283921869824,0.7616260677000949,0.1889574647881434,"['GABARAPL2', 'MAP1LC3A', 'BRAF', 'HRAS', 'GABARAP']",0.9998486240585546,0,0,5
198,Pathways in clear cell renal cell carcinoma WP4018,0.780283921869824,0.7616260677000949,0.1889574647881434,"['SETD2', 'ME1', 'GRB10', 'ALDOA', 'ACACA']",0.9998486240585546,0,0,5
199,Wnt Signaling Pathway WP363,0.7926829792759428,0.6799915546484623,0.1579837374948188,"['RYK', 'CSNK1G1']",0.9998486240585546,0,0,2
200,Neural Crest Cell Migration during Development WP4564,0.7926829792759428,0.6799915546484623,0.1579837374948188,"['TRIO', 'PAK4']",0.9998486240585546,0,0,2
201,NO/cGMP/PKG mediated Neuroprotection WP4008,0.7926829792759428,0.6799915546484623,0.1579837374948188,"['CYCS', 'CNGB1']",0.9998486240585546,0,0,2
202,Trans-sulfuration and one-carbon metabolism WP2525,0.7995797187828805,0.6316270566727605,0.14127541796052964,['AHCY'],0.9998486240585546,0,0,1
203,FOXA2 pathway WP5066,0.7995797187828805,0.6316270566727605,0.14127541796052964,['ACACA'],0.9998486240585546,0,0,1
204,GDNF/RET signaling axis WP4830,0.7995797187828805,0.6316270566727605,0.14127541796052964,['PAX2'],0.9998486240585546,0,0,1
205,Hippo-Yap signaling pathway WP4537,0.7995797187828805,0.6316270566727605,0.14127541796052964,['MAP4K3'],0.9998486240585546,0,0,1
206,miRNA regulation of p53 pathway in prostate cancer WP3982,0.7995797187828805,0.6316270566727605,0.14127541796052964,['BAX'],0.9998486240585546,0,0,1
207,miRNA targets in ECM and membrane receptors WP2911,0.7995797187828805,0.6316270566727605,0.14127541796052964,['COL4A1'],0.9998486240585546,0,0,1
208,One-carbon metabolism WP241,0.7995797187828805,0.6316270566727605,0.14127541796052964,['AHCY'],0.9998486240585546,0,0,1
209,Proteoglycan biosynthesis WP4784,0.7995797187828805,0.6316270566727605,0.14127541796052964,['EXT2'],0.9998486240585546,0,0,1
210,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.7995797187828805,0.6316270566727605,0.14127541796052964,['BAX'],0.9998486240585546,0,0,1
211,Prolactin Signaling Pathway WP2037,0.8003427501946847,0.7212256121513684,0.16062791029529008,"['RPS6', 'PPIB', 'HRAS', 'PTK2']",0.9998486240585546,0,0,4
212,Proximal tubule transport WP4917,0.8008467381898093,0.6976576055523424,0.15493976953475505,"['SLC7A9', 'SLC6A20', 'ATP6V1F']",0.9998486240585546,0,0,3
213,Monoamine GPCRs WP58,0.8087183389464814,0.6547389109145743,0.13900407084505903,"['CHRM3', 'CHRM5']",0.9998486240585546,0,0,2
214,Complement system WP2806,0.8136862098465911,0.7239434501428786,0.1492630072394005,"['LAMA5', 'FKBP2', 'RPS19', 'CD59', 'TXN']",0.9998486240585546,0,0,5
215,16p11.2 distal deletion syndrome WP4950,0.8199603427904936,0.5894576477757465,0.11700693184479555,['CD81'],0.9998486240585546,0,0,1
216,Striated Muscle Contraction Pathway WP383,0.8199603427904936,0.5894576477757465,0.11700693184479555,['TPM2'],0.9998486240585546,0,0,1
217,Ebstein-Barr virus LMP1 signaling WP262,0.8199603427904936,0.5894576477757465,0.11700693184479555,['TRADD'],0.9998486240585546,0,0,1
218,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.8199603427904936,0.5894576477757465,0.11700693184479555,['RPS6'],0.9998486240585546,0,0,1
219,TGF-beta Signaling Pathway WP366,0.835266570892742,0.7158067158067158,0.1288483286898485,"['PARD6A', 'CITED1', 'SUMO1', 'NEDD4L', 'BTRC', 'PTK2']",0.9998486240585546,0,0,6
220,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.8375040849678337,0.6094583083572578,0.10807471629806135,"['TNFSF4', 'RPS6']",0.9998486240585546,0,0,2
221,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.8375040849678337,0.6094583083572578,0.10807471629806135,"['MAP4K3', 'PAK4']",0.9998486240585546,0,0,2
222,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.8375040849678337,0.6094583083572578,0.10807471629806135,"['TRADD', 'PIN1']",0.9998486240585546,0,0,2
223,PDGFR-beta pathway WP3972,0.83827015266836,0.5525594149908593,0.09747968772999213,['HRAS'],0.9998486240585546,0,0,1
224,Hippo-Merlin Signaling Dysregulation WP4541,0.8438411339566392,0.7061891643709826,0.11990458701483983,"['NTRK2', 'ITGAE', 'HRAS', 'CDH8', 'PTK2', 'PAK4']",0.9998486240585546,0,0,6
225,MAPK Signaling Pathway WP382,0.844837200049515,0.7744667033021931,0.13058386309180117,"['NTRK2', 'GADD45A', 'RRAS2', 'BRAF', 'FGF17', 'CACNA1I', 'DDIT3', 'NF1', 'RAC3', 'RAPGEF2', 'PTPN7', 'HRAS', 'MAP4K3']",0.9998486240585546,0,0,13
226,EGF/EGFR signaling pathway WP437,0.8489913070985928,0.7277003765210216,0.11912915922563184,"['NDUFA13', 'ATXN2', 'RALB', 'GRB10', 'BRAF', 'NEDD8', 'HRAS', 'PTK2']",0.9998486240585546,0,0,8
227,DNA damage response WP707,0.8492474478709499,0.6309523809523809,0.10310057007647182,"['GADD45A', 'CYCS', 'BAX']",0.9998486240585546,0,0,3
228,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.8492474478709499,0.6309523809523809,0.10310057007647182,"['BAX', 'HRAS', 'PTK2']",0.9998486240585546,0,0,3
229,Angiogenesis WP1539,0.8547193844229055,0.5200021507688999,0.0816310136524839,['PTK2'],0.9998486240585546,0,0,1
230,Canonical and non-canonical Notch signaling WP3845,0.8547193844229055,0.5200021507688999,0.0816310136524839,['DLL3'],0.9998486240585546,0,0,1
231,Estrogen signaling pathway WP712,0.8547193844229055,0.5200021507688999,0.0816310136524839,['BRAF'],0.9998486240585546,0,0,1
232,miRNA regulation of DNA damage response WP1530,0.8596212069694089,0.6162151801686685,0.09321083025971934,"['GADD45A', 'CYCS', 'BAX']",0.9998486240585546,0,0,3
233,Thermogenesis WP4321,0.8627794488818702,0.6421464877926839,0.0947783710703992,"['RPS6KA6', 'RPS6', 'FRS2', 'HRAS']",0.9998486240585546,0,0,4
234,NRF2 pathway WP2884,0.8674071892956308,0.6788161333615879,0.09655939512262648,"['FTH1', 'GSTP1', 'ME1', 'TXN', 'SLC6A20', 'FTL']",0.9998486240585546,0,0,6
235,16p11.2 proximal deletion syndrome WP4949,0.8693634846378929,0.6021478521478522,0.08429706350549954,"['TMEM219', 'ALDOA', 'SEZ6L2']",0.9998486240585546,0,0,3
236,Fluoropyrimidine Activity WP1601,0.8694969478357548,0.49106236034938044,0.06867038412369972,['TK1'],0.9998486240585546,0,0,1
237,Inflammatory Response Pathway WP453,0.8694969478357548,0.49106236034938044,0.06867038412369972,['LAMA5'],0.9998486240585546,0,0,1
238,Lipid Metabolism Pathway WP3965,0.8694969478357548,0.49106236034938044,0.06867038412369972,['ACACA'],0.9998486240585546,0,0,1
239,Oxidative Stress WP408,0.8694969478357548,0.49106236034938044,0.06867038412369972,['NOX1'],0.9998486240585546,0,0,1
240,Pregnane X receptor pathway WP2876,0.8694969478357548,0.49106236034938044,0.06867038412369972,['PSMC5'],0.9998486240585546,0,0,1
241,Genes related to primary cilium development (based on CRISPR) WP4536,0.8785037846054656,0.5887057387057387,0.07625803514774869,"['DYNLT1', 'TTC21B', 'DYNLL1']",0.9998486240585546,0,0,3
242,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.8827725877240507,0.4651688636582315,0.05800081553049144,['PPIB'],0.9998486240585546,0,0,1
243,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.8827725877240507,0.4651688636582315,0.05800081553049144,['HRAS'],0.9998486240585546,0,0,1
244,GABA receptor Signaling WP4159,0.8827725877240507,0.4651688636582315,0.05800081553049144,['SLC32A1'],0.9998486240585546,0,0,1
245,Phosphoinositides metabolism WP4971,0.8827725877240507,0.4651688636582315,0.05800081553049144,['SBF2'],0.9998486240585546,0,0,1
246,Notch Signaling Pathway Netpath WP61,0.8930660612585292,0.5195629944567031,0.05875983349429254,"['PSENEN', 'DLL3']",0.9998486240585546,0,0,2
247,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.8946988269278795,0.4418647166361974,0.04916545788926569,['SBF2'],0.9998486240585546,0,0,1
248,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.8946988269278795,0.4418647166361974,0.04916545788926569,['NTRK2'],0.9998486240585546,0,0,1
249,Apoptosis WP254,0.8950946626722502,0.5635375263034837,0.06245449602818458,"['TRADD', 'CYCS', 'BAX']",0.9998486240585546,0,0,3
250,Folate Metabolism WP176,0.9018100728463122,0.5046660567246112,0.0521579149033649,"['AHCY', 'GPX4']",0.9998486240585546,0,0,2
251,White fat cell differentiation WP4149,0.9054127122648064,0.42078001218769046,0.04181055495073883,['DDIT3'],0.9998486240585546,0,0,1
252,Heart Development WP1591,0.9054127122648064,0.42078001218769046,0.04181055495073883,['VEGFB'],0.9998486240585546,0,0,1
253,Head and Neck Squamous Cell Carcinoma WP4674,0.9096207332380325,0.5404238618524333,0.05119302461632507,"['RPS6', 'CSMD3', 'HRAS']",0.9998486240585546,0,0,3
254,ATM Signaling Pathway WP2516,0.91503738301806,0.4016120990526841,0.03565928236678148,['GADD45A'],0.9998486240585546,0,0,1
255,Endothelin Pathways WP2197,0.91503738301806,0.4016120990526841,0.03565928236678148,['RIIAD1'],0.9998486240585546,0,0,1
256,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.91503738301806,0.4016120990526841,0.03565928236678148,['DDIT3'],0.9998486240585546,0,0,1
257,Prion disease pathway WP3995,0.91503738301806,0.4016120990526841,0.03565928236678148,['PTK2'],0.9998486240585546,0,0,1
258,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.91503738301806,0.4016120990526841,0.03565928236678148,['STAR'],0.9998486240585546,0,0,1
259,Oncostatin M Signaling Pathway WP2374,0.9173305193944239,0.47728790089265843,0.04118394926023662,"['RPS6', 'HRAS']",0.9998486240585546,0,0,2
260,Apoptosis Modulation and Signaling WP1772,0.9194764912990014,0.5601385069762705,0.04702407694522424,"['ENDOG', 'TRADD', 'CYCS', 'BAX']",0.9998486240585546,0,0,4
261,ATM Signaling Network in Development and Disease  WP3878,0.9236834818036342,0.38411096097289565,0.03049296291081944,['DCLRE1C'],0.9998486240585546,0,0,1
262,Genes controlling nephrogenesis WP4823,0.9236834818036342,0.38411096097289565,0.03049296291081944,['PAX2'],0.9998486240585546,0,0,1
263,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.9236834818036342,0.38411096097289565,0.03049296291081944,['LAMA5'],0.9998486240585546,0,0,1
264,PDGF Pathway WP2526,0.9236834818036342,0.38411096097289565,0.03049296291081944,['HRAS'],0.9998486240585546,0,0,1
265,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.9236834818036342,0.38411096097289565,0.03049296291081944,['BAX'],0.9998486240585546,0,0,1
266,G Protein Signaling Pathways WP35,0.9280065685246428,0.5090870667793744,0.03803718756958179,"['GNG10', 'GNG3', 'HRAS']",0.9998486240585546,0,0,3
267,Focal Adhesion WP306,0.929415031169978,0.6444549252122356,0.047174029300051615,"['LAMA5', 'COL4A1', 'VEGFB', 'RAC3', 'BRAF', 'HRAS', 'PTK2', 'ARHGAP35', 'PAK4']",0.9998486240585546,0,0,9
268,Breast cancer pathway WP4262,0.9299378093069494,0.5942365431640202,0.0431638965894544,"['FGF17', 'GADD45A', 'BAX', 'BRAF', 'HRAS', 'DLL3']",0.9998486240585546,0,0,6
269,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.9305221431132962,0.4527177610434701,0.03259993713889314,"['TMSB4X', 'PTK2']",0.9998486240585546,0,0,2
270,Prader-Willi and Angelman Syndrome WP3998,0.9305221431132962,0.4527177610434701,0.03259993713889314,"['POMC', 'FEZ1']",0.9998486240585546,0,0,2
271,Tryptophan metabolism WP465,0.9314504211229684,0.36806825106642294,0.02613737863445839,['HSD17B10'],0.9998486240585546,0,0,1
272,Energy Metabolism WP1541,0.9314504211229684,0.36806825106642294,0.02613737863445839,['UCP3'],0.9998486240585546,0,0,1
273,Notch Signaling WP268,0.9314504211229684,0.36806825106642294,0.02613737863445839,['DLL3'],0.9998486240585546,0,0,1
274,Rett syndrome causing genes WP4312,0.9314504211229684,0.36806825106642294,0.02613737863445839,['BRAF'],0.9998486240585546,0,0,1
275,Pathways affected in adenoid cystic carcinoma WP3651,0.9363461627222905,0.44135407136322047,0.029027874445441727,"['SETD2', 'HRAS']",0.9998486240585546,0,0,2
276,Glioblastoma signaling pathways WP2261,0.9382843674106328,0.49013024013024015,0.031222380645693874,"['NF1', 'BRAF', 'HRAS']",0.9998486240585546,0,0,3
277,Cardiac Progenitor Differentiation WP2406,0.9384275227081263,0.35330895795246803,0.022452661564442093,['MESP1'],0.9998486240585546,0,0,1
278,Hedgehog Signaling Pathway WP4249,0.9384275227081263,0.35330895795246803,0.022452661564442093,['CSNK1G1'],0.9998486240585546,0,0,1
279,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.9446950406699315,0.3396849950780481,0.019325736420679994,['PMVK'],0.9998486240585546,0,0,1
280,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.9446950406699315,0.3396849950780481,0.019325736420679994,['HRAS'],0.9998486240585546,0,0,1
281,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.9446950406699315,0.3396849950780481,0.019325736420679994,['MAP1LC3A'],0.9998486240585546,0,0,1
282,Fas ligand pathway and stress induction of heat shock proteins WP314,0.9446950406699315,0.3396849950780481,0.019325736420679994,['CYCS'],0.9998486240585546,0,0,1
283,Integrated Cancer Pathway WP1971,0.9446950406699315,0.3396849950780481,0.019325736420679994,['BAX'],0.9998486240585546,0,0,1
284,One-carbon metabolism and related pathways WP3940,0.9446950406699315,0.3396849950780481,0.019325736420679994,['GPX4'],0.9998486240585546,0,0,1
285,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.9466333160562579,0.42025007624275695,0.02304797103419023,"['IFI27L2', 'HRAS']",0.9998486240585546,0,0,2
286,IL-5 signaling pathway WP127,0.9503250813814531,0.3270702146387704,0.016664607489363718,['RPS6'],0.9998486240585546,0,0,1
287,G1 to S cell cycle control WP45,0.9511628654176512,0.4104342645588204,0.020550432991433047,"['GADD45A', 'MNAT1']",0.9998486240585546,0,0,2
288,Metapathway biotransformation Phase I and II WP702,0.9522417965067796,0.5308389521388306,0.025977288115780664,"['GSTK1', 'CYP2C8', 'GPX4', 'GSTO1', 'GSTP1']",0.9998486240585546,0,0,5
289,Chemokine signaling pathway WP3929,0.9553469080930204,0.5244648318042814,0.023957946820707333,"['GNG10', 'GNG3', 'BRAF', 'HRAS', 'PTK2']",0.9998486240585546,0,0,5
290,Development of ureteric collection system WP5053,0.95538242998364,0.3153564899451554,0.01439399552410187,['PAX2'],0.9998486240585546,0,0,1
291,Oxidation by Cytochrome P450 WP43,0.95538242998364,0.3153564899451554,0.01439399552410187,['CYP2C8'],0.9998486240585546,0,0,1
292,Calcium Regulation in the Cardiac Cell WP536,0.9573869892905154,0.5447729402743461,0.023723549596076587,"['CHRM3', 'PKIB', 'GNG3', 'CHRM5', 'ATP1A4', 'RGS6']",0.9998486240585546,0,0,6
293,Pre-implantation embryo WP3527,0.9599252930404933,0.3044506083338587,0.012451974257075641,['DDIT3'],0.9998486240585546,0,0,1
294,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9610109269357393,0.5121612972050352,0.020368398553449876,"['NTRK2', 'RPS6', 'FRS2', 'EIF2S2', 'HRAS']",0.9998486240585546,0,0,5
295,B Cell Receptor Signaling Pathway WP23,0.9615259452272373,0.44084249084249083,0.017295895347149055,"['CD81', 'BRAF', 'HRAS']",0.9998486240585546,0,0,3
296,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9640059660153563,0.2942717854966484,0.010787354957147995,['ACACA'],0.9998486240585546,0,0,1
297,Vitamin A and carotenoid metabolism WP716,0.9640059660153563,0.2942717854966484,0.010787354957147995,['RBP7'],0.9998486240585546,0,0,1
298,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.9640059660153563,0.2942717854966484,0.010787354957147995,['BAX'],0.9998486240585546,0,0,1
299,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.9640059660153563,0.2942717854966484,0.010787354957147995,['TRADD'],0.9998486240585546,0,0,1
300,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.9660087808426505,0.5004170141784821,0.017305598788177383,"['NTRK2', 'SST', 'AVP', 'ALDOA', 'HDAC9']",0.9998486240585546,0,0,5
301,Myometrial relaxation and contraction pathways WP289,0.9670741875601835,0.5229795706843412,0.017509391157472746,"['PKIB', 'GNG3', 'GSTO1', 'CRH', 'IGFBP6', 'RGS6']",0.9998486240585546,0,0,6
302,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.9676714332879958,0.28474966090700005,0.009357636344645986,['RPS6'],0.9998486240585546,0,0,1
303,Microglia Pathogen Phagocytosis Pathway WP3937,0.9676714332879958,0.28474966090700005,0.009357636344645986,['RAC3'],0.9998486240585546,0,0,1
304,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9682694785947641,0.46369820058854744,0.01495187589528105,"['RPS6KA6', 'DIO2', 'HRAS', 'MAP4K3']",0.9998486240585546,0,0,4
305,Endoderm differentiation WP2853,0.9682694785947641,0.46369820058854744,0.01495187589528105,"['TNRC6C', 'ACACA', 'AHDC1', 'NME1']",0.9998486240585546,0,0,4
306,Mesodermal commitment pathway WP2857,0.9682798238504488,0.4947428100195856,0.015947618527840622,"['EXT2', 'SETD2', 'RPL38', 'ACACA', 'AHDC1']",0.9998486240585546,0,0,5
307,Fragile X Syndrome  WP4549,0.9697835325652238,0.4197191697191697,0.012877989225547583,"['NTRK2', 'NF1', 'BRAF']",0.9998486240585546,0,0,3
308,Glycolysis and Gluconeogenesis WP534,0.970963906748394,0.2758226691042048,0.008127385968117004,['ALDOA'],0.9998486240585546,0,0,1
309,Phosphodiesterases in neuronal function WP4222,0.970963906748394,0.2758226691042048,0.008127385968117004,['PDE6G'],0.9998486240585546,0,0,1
310,ESC Pluripotency Pathways WP3931,0.9721416555979678,0.41311813186813184,0.011672135975525152,"['FGF17', 'BRAF', 'HRAS']",0.9998486240585546,0,0,3
311,TGF-beta Receptor Signaling WP560,0.9739213104450981,0.26743670710763945,0.007066953127405013,['HRAS'],0.9998486240585546,0,0,1
312,Interferon type I signaling pathways WP585,0.9739213104450981,0.26743670710763945,0.007066953127405013,['RPS6'],0.9998486240585546,0,0,1
313,Retinoblastoma gene in cancer WP2446,0.9762609445813554,0.3457653875822973,0.008307140350647542,"['H2AFZ', 'SKP2']",0.9998486240585546,0,0,2
314,IL-3 signaling pathway WP286,0.9765777156889726,0.2595440369932251,0.006151439172485279,['HRAS'],0.9998486240585546,0,0,1
315,Prostaglandin Synthesis and Regulation WP98,0.9765777156889726,0.2595440369932251,0.006151439172485279,['S100A6'],0.9998486240585546,0,0,1
316,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.9789637320328181,0.25210237659963436,0.0053598687299759576,['HRAS'],0.9998486240585546,0,0,1
317,Cardiac Hypertrophic Response WP2795,0.9789637320328181,0.25210237659963436,0.0053598687299759576,['HDAC9'],0.9998486240585546,0,0,1
318,Insulin Signaling WP481,0.9792070124334482,0.4632061805890874,0.009732983621861245,"['RPS6KA6', 'XBP1', 'GRB10', 'HRAS', 'MAP4K3']",0.9998486240585546,0,0,5
319,DNA damage response (only ATM dependent) WP710,0.9799398524626174,0.38865546218487396,0.007875747025735489,"['RAC3', 'BAX', 'HRAS']",0.9998486240585546,0,0,3
320,"GPCRs, Other WP117",0.9802356476263319,0.3326485870634743,0.006640424057284458,"['CHRM3', 'ADGRL2']",0.9998486240585546,0,0,2
321,RANKL/RANK signaling pathway WP2018,0.9811068589108954,0.24507414178346537,0.004674518887659778,['PTK2'],0.9998486240585546,0,0,1
322,Cell cycle WP179,0.9830100840469281,0.37747252747252746,0.00646833165231191,"['GADD45A', 'SKP2', 'ANAPC11']",0.9998486240585546,0,0,3
323,Neural Crest Differentiation WP2064,0.985013849920364,0.31473010064043916,0.0047522914127713645,"['HDAC9', 'DLL3']",0.9998486240585546,0,0,2
324,Peptide GPCRs WP24,0.9863136532973839,0.22615197112454882,0.0031165705009644756,['HCRTR1'],0.9998486240585546,0,0,1
325,Gastrin signaling pathway WP4659,0.9867868070910749,0.3618470570525365,0.004813023161511431,"['RPS6', 'HRAS', 'PTK2']",0.9998486240585546,0,0,3
326,AMP-activated protein kinase (AMPK) signaling WP1403,0.9889611234170143,0.21507557854371961,0.0023873942207407245,['ACACA'],0.9998486240585546,0,0,1
327,Hepatitis B infection WP4666,0.9891493995401173,0.39099704654241774,0.00426573772191164,"['CYCS', 'BAX', 'BRAF', 'HRAS']",0.9998486240585546,0,0,4
328,Joubert Syndrome WP4656,0.9910967461948176,0.20502954806343268,0.0018336047947997973,['PDE6G'],0.9998486240585546,0,0,1
329,Endochondral Ossification with Skeletal Dysplasias WP4808,0.9920043085228226,0.20034901113511716,0.001608367489059937,['CTSV'],0.9998486240585546,0,0,1
330,Endochondral Ossification WP474,0.9920043085228226,0.20034901113511716,0.001608367489059937,['CTSV'],0.9998486240585546,0,0,1
331,Adipogenesis WP236,0.9927202820274583,0.32994505494505494,0.0024106922111500634,"['GADD45A', 'CELF1', 'DDIT3']",0.9998486240585546,0,0,3
332,AGE/RAGE pathway WP2324,0.9935514486711788,0.19159844209522295,0.0012395332946936795,['CYCS'],0.9998486240585546,0,0,1
333,Ciliopathies WP4803,0.9936188322930538,0.3957765104554095,0.002533608603158725,"['TBC1D32', 'TTC21B', 'CCNQ', 'CCDC28B', 'CNGB1']",0.9998486240585546,0,0,5
334,Spinal Cord Injury WP2431,0.9938740509911316,0.3218306084159743,0.001977581381450544,"['COL4A1', 'GADD45A', 'APEX1']",0.9998486240585546,0,0,3
335,Ectoderm Differentiation WP2858,0.9938740509911316,0.3218306084159743,0.001977581381450544,"['CTNND2', 'CDH8', 'LY6E']",0.9998486240585546,0,0,3
336,Pathways Regulating Hippo Signaling WP4540,0.9941265985844691,0.2667664753666584,0.0015714459913999345,"['NTRK2', 'CDH8']",0.9998486240585546,0,0,2
337,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9947234656951255,0.5018834563345633,0.0026552166220063355,"['FGF17', 'LAMA5', 'GNG10', 'GNG3', 'COL4A1', 'RPS6', 'VEGFB', 'ITGAE', 'HRAS', 'PTK2', 'ACACA']",0.9998486240585546,0,0,11
338,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9953296026442624,0.17981196134761035,0.0008417605205290755,['HDAC9'],0.9998486240585546,0,0,1
339,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.9953296026442624,0.17981196134761035,0.0008417605205290755,['RYK'],0.9998486240585546,0,0,1
340,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9953296026442624,0.17981196134761035,0.0008417605205290755,['PTPRD'],0.9998486240585546,0,0,1
341,Vitamin D Receptor Pathway WP2877,0.9958644307458705,0.3445660574037131,0.001427931487163771,"['GADD45A', 'TNFSF4', 'S100A6', 'NOX1']",0.9998486240585546,0,0,4
342,T-cell receptor (TCR) signaling pathway WP69,0.996233482254916,0.1727246657346668,0.000651798796394834,['HRAS'],0.9998486240585546,0,0,1
343,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9966175473675727,0.16938545914779918,0.0005739094510576746,['RYK'],0.9998486240585546,0,0,1
344,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9966745137602803,0.2963020125941474,0.000986990288091768,"['COL4A1', 'HRAS', 'DLL3']",0.9998486240585546,0,0,3
345,Nuclear Receptors Meta-Pathway WP2882,0.9976352787258793,0.4402450692922621,0.0010422897298051244,"['PSMC5', 'FTH1', 'GSTP1', 'AIP', 'ME1', 'BAX', 'TXN', 'SLC6A20', 'FTL']",0.9998486240585546,0,0,9
346,PI3K-Akt signaling pathway WP4172,0.9978049907705073,0.4670852291047182,0.0010263832617622318,"['FGF17', 'LAMA5', 'NTRK2', 'GNG10', 'GNG3', 'COL4A1', 'RPS6', 'VEGFB', 'COL9A3', 'HRAS', 'PTK2']",0.9998486240585546,0,0,11
347,Male infertility WP4673,0.9991639012625977,0.1353255519617494,0.00011319284992976236,['PEX10'],0.9998486240585546,0,0,1
348,Wnt signaling WP428,0.9992490304311374,0.13326131516259487,0.00010011278792900124,['RYK'],0.9998486240585546,0,0,1
349,"GPCRs, Class A Rhodopsin-like WP455",0.9996112607185812,0.26956215187195937,0.00010480977037396792,"['CHRM3', 'CHRM5', 'OR6A2', 'HCRTR1']",0.9998486240585546,0,0,4
350,Osteoblast differentiation WP4787,0.9996453656575194,0.12039518168841251,4.2703838667413776e-05,['DLL3'],0.9998486240585546,0,0,1
351,Regulation of toll-like receptor signaling pathway WP1449,0.9998486240585546,0.10841402035795698,1.64125166589932e-05,['CUEDC2'],0.9998486240585546,0,0,1
